Avidity Biosciences, Inc. (RNA) Financials
Stock symbol RNA is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker RNA was renamed to
RNAM
effective 2026-02-26.
RNA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 2.0 billion | 269.5 million |
| Sept. 30, 2025 | 2.1 billion | 247.9 million |
| June 30, 2025 | 1.4 billion | 176.3 million |
| March 31, 2025 | 1.5 billion | 130.4 million |
RNA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -175.3 million | 43.4 million |
| Sept. 30, 2025 | -160.1 million | 19.0 million |
| June 30, 2025 | -203.0 million | 17.7 million |
| March 31, 2025 | -128.6 million | 17.7 million |
RNA Net Income
No data available :(
RNA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 1.7 billion | 90.6 million | 45.3 million |
| Sept. 30, 2025 | 1.9 billion | 46.0 million | 50.0 million |
| June 30, 2025 | 1.2 billion | 1.2 million | 5.1 million |
| March 31, 2025 | 1.4 billion | 2.1 million | 6.0 million |
RNA Shares Outstanding
RNA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 5.5 million | 166.6 million | 88.7 million | - |
| Sept. 30, 2025 | 3.9 million | 154.9 million | 46.3 million | - |
| June 30, 2025 | 3.3 million | 138.1 million | 36.9 million | - |
| March 31, 2025 | 3.8 million | 99.5 million | 33.6 million | - |
RNA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 860000 | 1.5 million |
| Sept. 30, 2025 | 12.5 million | - |
| June 30, 2025 | 3.8 million | 138.1 million |
| March 31, 2025 | 1.6 million | - |
RNA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
RNA
Price: $13.21
52 week price:
Earnings Per Share: -4.48 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 810900
Market Capitalization: 229.9 million